COMMUNIQUÉS West-GlobeNewswire

Eisai and Biogen Announce Presentation of Additional Data From the Phase II Clinical Trial of BAN2401 in Early Alzheimer’s Disease at the 2018 Clinical Trials on Alzheimer’s Disease (CTAD) Conference
25/10/2018
TOKYO and CAMBRIDGE, Mass., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB) (Headquarters: Cambridge, Massachusetts, United States, CEO: [...]
Press release: ONNI hammas Porvoo dental clinic to become a part of Terveystalo
25/10/2018
On 25 November 2018 Terveystalo has signed an agreement to acquire ONNI hammas dental clinic in Porvoo. The company's employees will be transferred to Terveystalo as old employees and the operations will continue on the [...]
GSW, a Syneos Health Advertising Company, Named Agency of the Year by Modern Healthcare & Ad Age
25/10/2018
Award Season Wins Include Industry Recognition for Digital, Print, Video and Social Media Campaigns COLUMBUS, Ohio, Oct. 25, 2018 (GLOBE NEWSWIRE) -- GSW, a Syneos Health TM Company and industry leader in healthcare [...]
United Health Products Engages Société Générale to Undertake Strategic Review
25/10/2018
HENDERSON, Nev., Oct. 25, 2018 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), manufacturer and marketer of HemoStyp ® , a patented hemostatic gauze for the healthcare and wound [...]
Foundational 10,000 Immunomes Project Uses Mass Cytometry to Establish a Reference Standard for the Human Immune System
25/10/2018
Providing the largest source of standardized, multi-omic immune data from healthy human subjects to accelerate translational research SOUTH SAN FRANCISCO, Calif., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation ( [...]
Scythian Biosciences Announces Name Change to SOL Global Investments Corp.
25/10/2018
TORONTO, Oct. 25, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the " Company ”) (CSE:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) is pleased to announce that the Company has changed its name from “Scythian [...]
Pieris Pharmaceuticals Appoints Matthew L. Sherman, M.D., to its Board of Directors
25/10/2018
BOSTON, Oct. 25, 2018 (GLOBE NEWSWIRE) -- Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) , a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin ® technology platform for [...]
Genocea to Host Third Quarter 2018 Financial Results Conference Call & Webcast on November 1, 2018 at 9:00 a.m. ET
25/10/2018
CAMBRIDGE, Mass., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, today announced that it will host a conference [...]
Inovio HIV Vaccine PENNVAX®-GP Delivered Intradermally Generated Robust, Long-Term Best-In-Class Antibody and T Cell Immune Responses
25/10/2018
PLYMOUTH MEETING, Pa., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced that its synthetic HIV vaccine PENNVAX ® -GP delivered via intradermal route demonstrated durable and [...]
Allena Pharmaceuticals to Present Data Characterizing Significant Unmet Need in Enteric Hyperoxaluria at ASN Kidney Week 2018
25/10/2018
– Highlights Additional Poster Presentation on the Design of URIROX-1, Ongoing Phase 3 Trial Evaluating Reloxaliase in Patients with Enteric Hyperoxaluria – NEWTON, Mass., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Allena [...]
Clearside Biomedical Appoints Thomas A. Ciulla, M.D., MBA as Chief Medical Officer
25/10/2018
ALPHARETTA, Ga., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]
Chembio Determines Not to Proceed with Proposed Public Offering of Common Stock
25/10/2018
MEDFORD, N.Y., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI) today announced that it has determined not to proceed with the proposed public offering of $25 million of its common stock [...]
RedHill Biopharma to Present at the BIO-Europe 2018 Conference
25/10/2018
TEL-AVIV, Israel and RALEIGH, N.C., Oct. 25, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]
The Joint Corp. to Host Conference Call on Thursday, November 8 to Discuss Third Quarter 2018 Results
25/10/2018
SCOTTSDALE, Ariz., Oct. 25, 2018 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics, announced it will report its third quarter 2018 financial results [...]
AMAG Pharmaceuticals to Host Third Quarter 2018 Financial Results Conference Call and Webcast on Thursday, November 1, 2018 at 8:00 a.m. ET
25/10/2018
WALTHAM, Mass., Oct. 25, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that its third quarter 2018 financial results will be released on Thursday, November 1, 2018 before the U.S. [...]
Fibrocell Receives Guidance from FDA on Phase 3 Clinical Trial Design for FCX-007
25/10/2018
Company Plans to Submit Phase 3 Protocol to FDA in Fourth Quarter of 2018 and Commence Trial in First Half of 2019 EXTON, Pa., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ: FCSC), a gene therapy [...]
SoldierStrong Honors The Vince and Linda McMahon Family Foundation At 5th Annual SoldierSalute Gala
25/10/2018
Nonprofit’s 2018 Notable Corporate and Individual Supporters to Also be Honored STAMFORD, Conn., Oct. 25, 2018 (GLOBE NEWSWIRE) -- SoldierStrong, a nonprofit organization dedicated to providing advanced medical [...]
Spark Therapeutics Launches New Initiative to Raise Awareness of the Importance of Genetic Testing for People Living with Inherited Retinal Diseases
25/10/2018
The Eye Want 2 Know digital resource helps patients and their families in the U.S. living with an inherited retinal disease (IRD) learn about genetic testing and includes a “Find A Provider” tool to locate health care [...]
Conatus Pharmaceuticals to Report Third Quarter 2018 Financial Results
25/10/2018
SAN DIEGO, Oct. 25, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) today announced that it will report financial results for the third quarter ended September 30, 2018, after the market close on [...]

Pages